FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent
Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.
JUNE 18, 2025
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.
According to a State Department memo, PrEP can only be dispensed to “pregnant and breastfeeding women” through PEPFAR.
Pre-exposure prophylaxis, or PrEP, could help change the tide on new HIV infections worldwide. But that's only if the most at-risk populations can access the treatment.
Hear why some of the leading HIV activists, organizations, and beyond support PrEP as a tool to end HIV.
The availability of a generic version likely means a lower cost of PrEP.